InvestSMART

USCOM Ltd (ASX: UCM) - Share Price

- Current share price for UCM : $0.012

Uscom Limited (UCM) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is an ASX listed medical technology company specialising in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company has three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring; the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers

UCM General Information +

ASX Code UCM
Website http://www.uscom.com.au
Industry/Sector Health Care Equipment
Market Cap ($M) 3
UCM Share Price $0.012
Day High $0.012
Day Low $0.012
Last Close $0.012
UCM Share Price Movement - ( No change )
Prices as at 16:35, 1 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

USCOM Ltd (UCM) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from USCOM Ltd (UCM) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

USCOM Ltd (UCM) price-sensitive announcements

UCM - Preliminary Final Report
The Preliminary Final Report of USCOM Ltd for the year ended 30 June 2025 outlines the com
USCOM Ltd (UCM)
29 Aug 2025 | 4:18 PM
UCM - Preliminary Final Report
The Preliminary Final Report for Uscom Limited for the year ended 30 June 2025 highlights
USCOM Ltd (UCM)
29 Aug 2025 | 4:18 PM
UCM - Quarterly Activities/Appendix 4C Cash Flow Report
The report is a quarterly activities and Appendix 4C cash flow update from USCOM Ltd for t
USCOM Ltd (UCM)
30 Jul 2025 | 10:03 AM
UCM - Quarterly Activities/Appendix 4C Cash Flow Report
This document is the quarterly activities report and Appendix 4C cash flow report for USCO
USCOM Ltd (UCM)
29 Apr 2025 | 10:05 AM

USCOM Ltd (UCM) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
USCOM Ltd (UCM)
ORDINARY FULLY PAID
Health Care $3 Suspension from Official Quotation - Annual Listing Fees 24 Aug 2026 10:50AM $0.012 $0.012 fallen by 0%
USCOM Ltd (UCM)
ORDINARY FULLY PAID
Health Care $3 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2026 9:39AM $0.012 $0.012 fallen by 0%
USCOM Ltd (UCM)
ORDINARY FULLY PAID
Health Care $3 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2026 9:39AM $0.012 $0.012 fallen by 0%
USCOM Ltd (UCM)
ORDINARY FULLY PAID
Health Care $3 Long Term Suspended Entities 10 Jul 2026 4:24PM $0.012 $0.012 fallen by 0%
USCOM Ltd (UCM)
ORDINARY FULLY PAID
Health Care $3 Quarterly Appendix 4C Cash Flow Report 15 Jun 2026 3:36PM $0.012 $0.012 fallen by 0%
USCOM Ltd (UCM)
ORDINARY FULLY PAID
Health Care $3 Final Director's Interest Notice - Bernecker 14 May 2026 11:58AM $0.012 $0.012 fallen by 0%

UCM Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$2.96 -$1.60 38.10% 0.00 0.00 0.00% 0.0%
2024A -$2.07 -$1.20 -20.80% 0.00 0.00 0.00% 0.0%
2023A -$2.59 -$1.50 29.60% 0.00 0.00 0.00% 0.0%

UCM Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Cochlear Limited (COH) $8,901M -0.3136 0.2540 0.0785 33.1345 26.4231 24.5000 2.53% 2.63% 2.87%
Fisher & Paykel Healthcare Corporation Limited (FPH) $21,395M 0.1388 0.1651 0.1747 55.0885 47.2810 40.2497 1.19% 1.29% 1.46%
ResMed Inc. (RMD) $19,361M 9.5922 0.0985 0.0885 21.2584 19.3522 17.7780 1.09% 1.19% 1.28%
USCOM Ltd (UCM) $3M 0.3814 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

UCM Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -60.00 0.00
Market 0.37 13.40 1.17 0.80
Sector 0.63 21.10 1.80 3.03

UCM Directors

Name Position Start Date
Mr Robert Allan Phillips Chief Executive Officer, Executive Chairman, Executive Director 23 Dec 1999
Mr Brett Thomas Crowley Company Secretary, Non Executive director 23 Aug 2018
Mr Xianhui Meng Non-Executive Director 16 Dec 2019

USCOM Ltd (UCM) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
25 Oct 2024 PHILLIPS, Robert Issued Related Securities 9,670,117 $0.026 $250,027.000
5 Mar 2024 PHILLIPS, Robert Issued Direct Shares 18,802,525 $0.037 $695,693.430
4 Mar 2024 PHILLIPS, Robert Issued Direct Shares 13,495,411 $0.037 $499,330.000

See all changes in directors' interest & trades for USCOM Ltd (UCM) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

UCM Management

Name Position
Nick Schicht General Manager

UCM Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in USCOM Ltd (UCM). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
0 (36.12%) Robert Allan Phillips
0 (21.11%) HSBC Custody Nominees
0 (12.20%) Neja Pty Ltd

UCM Calendar of Events

Date Event
26 February 2027 Report (Interim)
25 September 2026 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.